Research output: Contribution to journal › Article › peer-review
Expression of AhR-regulated miRNAs in non-small cell lung cancer in smokers and never smokers. / Kalinina, T S; Kononchuk, V V; Valembakhov, I S et al.
In: Biomeditsinskaia khimiia, Vol. 70, No. 1, 02.2024, p. 52-60.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Expression of AhR-regulated miRNAs in non-small cell lung cancer in smokers and never smokers
AU - Kalinina, T S
AU - Kononchuk, V V
AU - Valembakhov, I S
AU - Pustylnyak, V O
AU - Kozlov, V V
AU - Gulyaeva, L F
N1 - The work was carried out using the equipment of the Center for Collective Use “Proteomic Analysis”, supported by funding from the Ministry of Education and Science of Russia (agreement No. 075-15-2021-691). The study was supported by the Russian Science Foundation, project No. 22-15-00065.
PY - 2024/2
Y1 - 2024/2
N2 - Smoking is a risk factor for non-small cell lung cancer (NSCLC). The most common subtypes of NSCLC are lung adenocarcinoma (LAC) and squamous cell carcinoma (SCC). The cigarette smoke contains aryl hydrocarbon receptor (AhR) ligands, such as benzo(a)pyrene (BaP). By activating the AhR, BaP can change the expression of many genes, including miRNA-encoding genes. In this study, we have evaluated the expression of few miRNAs potentially regulated by AhR (miR-21, -342, -93, -181a, -146a), as well as CYP1A1, a known AhR target gene, in lung tumor samples from smoking (n=40) and non-smoking (n=30) patients with LAC and from smoking patients with SCC (n=40). We have also collected macroscopically normal lung tissue >5 cm from the tumor margin. We compared the obtained data on the miRNA expression in tumors with data from The Cancer Genome Atlas (TCGA). We found that in 76.7% of non-smoking LAC patients, CYP1A1 mRNA was not detected in tumor and normal lung tissues, while in smoking patients, CYP1A1 expression was detected in tumors in almost half of the cases (47.5% for SCC and 42.5% for LAC). The expression profile of AhR-regulated miRNAs differed between LAC and SCC and depended on the smoking status. In LAC patients, the expression of oncogenic miRNA-21 and miRNA-93 in tumors was higher than in normal lung tissue from the same patients. However, in SCC patients from our sample, the levels of these miRNAs in tumor and non-transformed lung tissue did not differ significantly. The results of our studies and TCGA data indicate that the expression levels of miRNA-181a and miRNA-146a in LAC are associated with smoking: expression of these miRNAs was significantly lower in tumors of smokers. It is possible that their expression is regulated by AhR and AhRR (AhR repressor), and inhibition of AhR by AhRR leads to a decrease in miRNA expression in tumors of smoking patients. Overall, these results confirm that smoking has an effect on the miRNA expression profile. This should be taken into account when searching for new diagnostic and therapeutic targets for NSCLC.
AB - Smoking is a risk factor for non-small cell lung cancer (NSCLC). The most common subtypes of NSCLC are lung adenocarcinoma (LAC) and squamous cell carcinoma (SCC). The cigarette smoke contains aryl hydrocarbon receptor (AhR) ligands, such as benzo(a)pyrene (BaP). By activating the AhR, BaP can change the expression of many genes, including miRNA-encoding genes. In this study, we have evaluated the expression of few miRNAs potentially regulated by AhR (miR-21, -342, -93, -181a, -146a), as well as CYP1A1, a known AhR target gene, in lung tumor samples from smoking (n=40) and non-smoking (n=30) patients with LAC and from smoking patients with SCC (n=40). We have also collected macroscopically normal lung tissue >5 cm from the tumor margin. We compared the obtained data on the miRNA expression in tumors with data from The Cancer Genome Atlas (TCGA). We found that in 76.7% of non-smoking LAC patients, CYP1A1 mRNA was not detected in tumor and normal lung tissues, while in smoking patients, CYP1A1 expression was detected in tumors in almost half of the cases (47.5% for SCC and 42.5% for LAC). The expression profile of AhR-regulated miRNAs differed between LAC and SCC and depended on the smoking status. In LAC patients, the expression of oncogenic miRNA-21 and miRNA-93 in tumors was higher than in normal lung tissue from the same patients. However, in SCC patients from our sample, the levels of these miRNAs in tumor and non-transformed lung tissue did not differ significantly. The results of our studies and TCGA data indicate that the expression levels of miRNA-181a and miRNA-146a in LAC are associated with smoking: expression of these miRNAs was significantly lower in tumors of smokers. It is possible that their expression is regulated by AhR and AhRR (AhR repressor), and inhibition of AhR by AhRR leads to a decrease in miRNA expression in tumors of smoking patients. Overall, these results confirm that smoking has an effect on the miRNA expression profile. This should be taken into account when searching for new diagnostic and therapeutic targets for NSCLC.
KW - Humans
KW - Carcinoma, Non-Small-Cell Lung/genetics
KW - MicroRNAs/genetics
KW - Receptors, Aryl Hydrocarbon/genetics
KW - Smokers
KW - Cytochrome P-450 CYP1A1/genetics
KW - Lung Neoplasms/genetics
KW - Carcinoma, Squamous Cell/genetics
UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85187208884&origin=inward&txGid=0efb89ea140072882fed38c26c5522b4
U2 - 10.18097/PBMC20247001052
DO - 10.18097/PBMC20247001052
M3 - Article
C2 - 38450681
VL - 70
SP - 52
EP - 60
JO - Biomeditsinskaya Khimiya
JF - Biomeditsinskaya Khimiya
SN - 2310-6905
IS - 1
ER -
ID: 60464874